Sartorius Stedim Biotech (DIM) Stock Chart & Stock Price History €171.65 -4.35 (-2.47%) As of 08/1/2025 Add Compare Share Share Chart Stock AnalysisChartHeadlinesBuy This Stock Sartorius Stedim Biotech Stock Price Performance The Sartorius Stedim Biotech (DIM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 6.79%, with a year-to-date return of -6.84%. In the past month, the stock has decreased 15.65%, reflecting recent market activity. As of the latest close, Sartorius Stedim Biotech traded at €176.00 with a market cap of and volume of 86,585 shares. Five years ago, the stock traded at €265.40, representing a 35.32% decrease over that period. At the time, it had a market cap of and a volume of 43,827 shares. Receive DIM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.91%1 Month Performance-15.65%3 Month Performance-16.76%Year-To-Date Performance-6.84%1 Year Performance-6.79%5 Year Performance-35.32% DIM Stock Chart for Saturday, August, 2, 2025 DIM Chart by TradingView Sartorius Stedim Biotech Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025€177.90€176.00-1.07%€179.80€175.8586,585 shs$0.0007/31/2025€179.55€177.90-0.92%€181.90€177.9055,539 shs$0.0007/30/2025€175.90€179.55+2.08%€181.15€176.3076,290 shs$0.0007/29/2025€175.00€175.90+0.51%€180.35€175.9093,089 shs$0.0007/28/2025€175.00€175.00€176.70€172.6071,463 shs$0.0007/25/2025€172.85€175.25+1.39%€177.00€172.0568,004 shs$0.0007/24/2025€175.00€172.85-1.23%€180.00€172.85144,287 shs$0.0007/23/2025€190.45€175.00-8.11%€192.00€166.70407,974 shs$0.0007/22/2025€190.35€190.45+0.05%€191.20€187.0079,704 shs$0.0007/21/2025€190.35€190.35€194.10€189.6883,369 shs$0.00 Get the Latest News and Ratings for DIM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025€194.35€192.90-0.75%€196.00€192.7037,845 shs$0.0007/17/2025€196.50€194.35-1.09%€196.60€192.6054,749 shs$0.0007/16/2025€196.15€196.50+0.18%€201.40€195.0555,538 shs$0.0007/15/2025€203.70€196.15-3.71%€204.00€195.1072,975 shs$0.0007/14/2025€203.70€203.70€205.50€202.7031,902 shs$0.0007/11/2025€200.40€205.70+2.64%€206.30€201.8034,861 shs$0.0007/10/2025€201.40€200.40-0.50%€205.30€199.4532,701 shs$0.0007/09/2025€200.20€201.40+0.60%€202.20€195.2555,366 shs$0.0007/08/2025€203.90€200.20-1.81%€203.80€200.0031,885 shs$0.0007/07/2025€203.90€203.90€206.70€201.0039,680 shs$0.0007/04/2025€205.10€204.00-0.54%€207.30€203.1029,677 shs$0.0007/03/2025€203.50€205.10+0.79%€206.30€200.5049,969 shs$0.0007/02/2025€202.80€203.50+0.35%€203.60€199.3072,587 shs$0.0007/01/2025€204.60€202.80-0.88%€207.20€202.4045,322 shs$0.00 Related Companies Fielmann Group Stock Price Chart Sartorius Aktiengesellschaft Stock Price Chart Sartorius Aktiengesellschaft Stock Price Chart Carl Zeiss Meditec Stock Price Chart Gerresheimer Stock Price Chart Fresenius SE & Co. KGaA Stock Price Chart Genfit Stock Price Chart Sanofi Stock Price Chart Siemens Healthineers Stock Price Chart Merck KGaA Stock Price Chart Receive DIM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (EPA:DIM) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sartorius Stedim Biotech S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sartorius Stedim Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
